Publications of Stefan H. E. Kaufmann
All genres
Journal Article (685)
2018
Journal Article
9, 661 (2018)
A Serum Circulating miRNA Signature for Short-Term Risk of Progression to Active Tuberculosis Among Household Contacts. Frontiers in immunology
Journal Article
26 (4), p. 248 - 248 (2018)
Our microbiome as a major player in health and disease (How Has Microbiology Changed over the Past 25 Years?). Trends in Microbiology
Journal Article
197 (6), pp. 801 - 813 (2018)
B Cells Producing Type I IFN Modulate Macrophage Polarization in Tuberculosis. American Journal of Respiratory and Critical Care Medicine
Journal Article
7, 199 (2018)
Progress and challenges in TB vaccine development. Faculty of 1000 Research
Journal Article
8 (1), 2675 (2018)
Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis. Scientific Reports
Journal Article
9, 180 (2018)
Editorial: Reassessing Twenty Years of Vaccine Development against Tuberculosis. Frontiers in immunology
Journal Article
9, 121 (2018)
Next-Generation Vaccines Based on Bacille Calmette–Guérin. Frontiers in immunology
Journal Article
8 (1), 1520 (2018)
IL-36/LXR axis modulates cholesterol metabolism and immune defense to Mycobacterium tuberculosis. Scientific Reports
Journal Article
46 (D1), pp. D1237 - D1247 (2018)
The SysteMHC Atlas project. Nucleic Acids Research
Journal Article
17 (1), pp. 35 - 56 (2018)
Host-directed therapies for bacterial and viral infections. Nature Reviews Drug Discovery 2017
Journal Article
13 (12), pp. 2041 - 2055 (2017)
The E3 ubiquitin ligase NEDD4 enhances killing of membrane-perturbing intracellular bacteria by promoting autophagy. Autophagy
Journal Article
8, 1744 (2017)
Efficacy Testing of H56 cDNA Tattoo Immunization against Tuberculosis in a Mouse Model. Frontiers in immunology
Journal Article
8, 1563 (2017)
Molecular Signatures of Immunity and Immunogenicity in Infection and Vaccination. Frontiers in immunology
Journal Article
12 (11), e0187882 (2017)
Pulmonary immune responses to Mycobacterium tuberculosis in exposed individuals. PLoS One
Journal Article
13 (10), e1006676 (2017)
Mycobacterium tuberculosis infection modulates adipose tissue biology. PLoS Pathogens
Journal Article
8 (Issue OCT), 1203 (2017)
TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development. Frontiers in immunology
Journal Article
7 (1), 12094 (2017)
Concordant and discordant gene expression patterns in mouse strains identify best-fit animal model for human tuberculosis. Scientific Reports
Journal Article
8, 1147 (2017)
The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing. Frontiers in immunology
Journal Article
2 (4), e00057-17 (2017)
Integration of Metabolomics and Transcriptomics Reveals a Complex Diet of Mycobacterium tuberculosis during Early Macrophage Infection. mSystems
Journal Article
7 (1), 8853 (2017)
NOS2-deficient mice with hypoxic necrotizing lung lesions predict outcomes of tuberculosis chemotherapy in humans. Scientific Reports